TERF1 and neuroblastoma: In turn, the TAMs secrete miR-155 in exosomes, which targets telomeric repeat binding factor 1 (TERF-1) in neuroblastoma cells, thereby increasing telomerase activity and subsequently cisplatin resistance [151].